MPMG
TEVA icon

Minneapolis Portfolio Management Group’s Teva Pharmaceuticals TEVA Stock Holding History

Minneapolis Portfolio Management Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-650,300
Closed -$20.9M – 27
2017
Q1 		$20.9M Buy
650,300
+53,676
+9% +$1.83M 3.48% 13
2016
Q4 		$21.6M Buy
596,624
+82,765
+16% +$3.3M 3.75% 14
2016
Q3 		$23.6M Buy
513,859
+881
+0.2% +$46K 4.11% 11
2016
Q2 		$25.8M Buy
512,978
+84,007
+20% +$4.47M 4.64% 8
2016
Q1 		$23M Sell
428,971
-25,294
-6% -$1.48M 3.82% 12
2015
Q4 		$29.8M Sell
454,265
-14,772
-3% -$913K 4.96% 13
2015
Q3 		$26.5M Sell
469,037
-7,288
-2% -$473K 4.43% 14
2015
Q2 		$28.2M Sell
476,325
-229,768
-33% -$14.2M 4.01% 14
2015
Q1 		$44M Sell
706,093
-24,083
-3% -$1.4M 6.47% 2
2014
Q4 		$42M Sell
730,176
-32,996
-4% -$1.84M 5.92% 5
2014
Q3 		$41M Buy
763,172
+1,710
+0.2% +$90.6K 5.32% 8
2014
Q2 		$39.9M Buy
761,462
+6,560
+0.9% +$335K 5.07% 9
2014
Q1 		$39.9M Buy
754,902
+284,684
+61% +$13.2M 4.94% 6
2013
Q4 		$18.8M Buy
+470,218
New +$18.5M 2.29% 20

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Minneapolis Portfolio Management Group's TEVA Position: Q2 2017 in Review

Minneapolis Portfolio Management Group sold out of Teva Pharmaceuticals (TEVA) in Q2 2017, closing a stake of 650,300 shares — an estimated $20.9M sold.

Minneapolis Portfolio Management Group first reported a position in TEVA in Q4 2013 and held it in 14 quarters. The position peaked at $44M in Q1 2015. 649 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • Minneapolis Portfolio Management Group reported no remaining Teva Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Minneapolis Portfolio Management Group sold 650,300 Teva Pharmaceuticals shares in Q2 2017, an estimated $20.9M.
  • Minneapolis Portfolio Management Group first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 14 quarters.
  • Minneapolis Portfolio Management Group's Teva Pharmaceuticals position peaked at $44M in Q1 2015.
  • 649 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on Minneapolis Portfolio Management Group's 13F filing for Q2 2017, filed 7 Aug 2017.